364 results on '"Gimenez Arnau, Ana"'
Search Results
2. Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status
3. Occupational Contact Urticaria Syndrome
4. Occupational Contact Dermatitis in the Industrial Setting
5. Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment
6. Non–Skin Related Symptoms Are Common in Chronic Spontaneous Urticaria and Linked to Active and Uncontrolled Disease: Results From the Chronic Urticaria Registry
7. Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials
8. Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Urticaria Are Underused in Clinical Practice
9. Acute and Chronic Urticaria Diagnosis and Management Taking into Account Their Differences
10. Remibrutinib demonstrates favorable safety profile and sustained efficacy in chronic spontaneous urticaria over 52 weeks
11. Drug Photosensitivity
12. Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials
13. Autoimmune Diseases and Low Baseline IgE in Chronic Spontaneous Urticaria: A Clinical and Therapeutic Prospective Analysis in Real-Life Clinical Practice
14. Recent updates in urticaria
15. Patients With Chronic Spontaneous Urticaria Who Have Wheals, Angioedema, or Both, Differ Demographically, Clinically, and in Response to Treatment—Results From CURE
16. Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study
17. Urticarial Vasculitis Differs From Chronic Spontaneous Urticaria in Time to Diagnosis, Clinical Presentation, and Need for Anti-Inflammatory Treatment: An International Prospective UCARE Study
18. The Benefit of Complete Response to Treatment in Patients With Chronic Spontaneous Urticaria—CURE Results
19. Contact Dermatitis: Overcoming Challenges of Specific Patients, Deciphering the Results and Reaching a Correct Diagnosis
20. Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria
21. Urticaria Therapy and Management. Looking Forward
22. Databases and Networks: The Benefit for Research and Quality Assurance in Patch Testing
23. Occupational Contact Dermatitis: Health Personnel
24. Chronic hand eczema: clinical characterization, aetiology, concomitant foot eczema and polysensitization
25. Safety of Remibrutinib Across Immune-mediated Diseases Supports Development in Multiple Sclerosis (P8-6.015)
26. Enhancing Angioedema Patient Care: Unveiling Underutilization and Barriers in the Implementation of Patient-Reported Outcome Measurements
27. Dupilumab Reduces Disease Activity in Patients with Chronic Spontaneous Urticaria: LIBERTY-CSU CUPID Study A
28. Efficacy of Remibrutinib in Patients With Chronic Spontaneous Urticaria With or Without Prior Exposure to Biologics in the Phase 3 REMIX-1 and REMIX-2 Studies
29. Efficacy and Safety of Rilzabrutinib in Patients With Chronic Spontaneous Urticaria: 12-Week Results From the RILECSU Phase 2 Dose-Ranging Study
30. Time to Relapse During Treatment-Free Follow-Up Without Remibrutinib in Patients With Chronic Spontaneous Urticaria: Subgroup Analysis By Baseline Immunoglobulin-E Levels and Chronic Urticaria Index Status From a Phase 2b Extension Study
31. Immediate and Delayed Hypersensitivity Reactions Occurring in the Kitchen: Hazards Related to Being a Chef or Kitchen Staff
32. Contact Urticaria
33. What lessons can we learn? Clinical and epidemiological retrospective analysis of 267 patients with urticaria in a Brazilian tertiary center
34. The Pathogenesis of Chronic Spontaneous Urticaria: The Role of Infiltrating Cells
35. How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study
36. CRUSE®-An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria
37. Clinical Diagnosis of Immediate Contact Skin Reactions
38. Immunoglobulin E: Pathogenic Relevance in Immediate Contact Reactions
39. Essentials and Updated Concepts
40. Management and Treatment of Contact Urticaria Syndrome
41. The usage, quality and relevance of information and communications technologies in patients with chronic urticaria: A UCARE study
42. Emerging Systemic Treatment Options in Atopic Dermatitis.
43. Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results
44. CRUSE®—An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria
45. Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials
46. Chronic urticaria phenotypes: clinical differences regarding triggers, activity, prognosis and therapeutic response
47. Usage prevalence of angioedema patient–reported outcome measures: Results from the UCARE and ACARE PROMUSE study
48. Low-level NLRP3 somatic mosaicism in adult-onset cryopyrin-associated periodic syndrome misdiagnosed as chronic urticaria
49. Relevance of the Basophil High-Affinity IgE Receptor in Chronic Urticaria: Clinical Experience from a Tertiary Care Institution
50. Differential diagnosis between urticarial vasculitis and chronic spontaneous urticaria: An international Delphi survey
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.